Skip to main content
Erschienen in: Obesity Surgery 2/2014

01.02.2014 | Original Contributions

Six-Month Intragastric Balloon Treatment for Obesity Improves Lung Function, Body Composition, and Metabolic Syndrome

verfasst von: Thiago Thomaz Mafort, Eduardo Madeira, Miguel Madeira, Erika Paniago Guedes, Rodrigo Oliveira Moreira, Laura Maria Carvalho de Mendonça, Maria Lucia Fleiuss Farias, Agnaldo José Lopes

Erschienen in: Obesity Surgery | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The purpose of this study is to establish whether the use of an intragastric balloon (IGB) for 6 months improves lung function, metabolic parameters, and body fat distribution in patients with overweight/obesity and metabolic syndrome (MS).

Methods

This is a longitudinal and interventional study on 40 adults, whose anthropometric, laboratory, and lung function parameters were assessed and who underwent dual-energy X-ray absorptiometry (DXA) before implantation and after removal of IGB.

Results

The total lung capacity (TLC) (p = 0.0001), functional residual capacity (FRC) (p = 0.0001), residual volume (p = 0.0005), and expiratory reserve volume (ERV) (p = 0.0001) were significantly reduced by IGB. The body mass index (BMI) significantly decreased from a median of 39.1 kg/m2 at the beginning of the study to 34.5 kg/m2 at the end of the 6-month period (p = 0.0001). At the end of the study, 31 participants (77.5 %) no longer met the diagnostic criteria of MS. The percentage of truncal, android, gynoid, and total fat investigated by DXA exhibited significant reductions (p = 0.0001). Significant correlations were found between delta TLC and delta waist circumference (ρ = −0.34; p = 0.03), delta FRC and delta IMC (ρ = −0.39; p = 0.01), delta ERV and delta BMI (ρ = −0.44; p = 0.005), and delta ERV and delta high-density lipoprotein (HDL) (ρ = −0.37; p = 0.02). Significant correlations were also found between delta ERV and delta truncal (ρ = −0.51; p = 0.004), android (ρ = −0.46; p = 0.01), gynoid (ρ = −0.55; p = 0.001), and total fat (ρ = −0.59; p = 0.0005).

Conclusions

IGB efficiently induced weight loss and promoted the improvement of lung function parameters, with a reduction of the restrictive ventilatory defect. It also promoted improvements of MS and the pattern of body fat distribution.
Literatur
1.
Zurück zum Zitat Aballay LR, Eynard AR, Díaz Mdel P, et al. Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America. Nutr Rev. 2013;71(3):168–79. Epub 2013 Jan 7. PMID 23452284.PubMedCrossRef Aballay LR, Eynard AR, Díaz Mdel P, et al. Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America. Nutr Rev. 2013;71(3):168–79. Epub 2013 Jan 7. PMID 23452284.PubMedCrossRef
4.
Zurück zum Zitat Imaz I, Martínez-Cervell C, García-Álvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity: a meta-analysis. Obes Surg. 2008;18(7):841–6. PMID: 18459025.PubMedCrossRef Imaz I, Martínez-Cervell C, García-Álvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity: a meta-analysis. Obes Surg. 2008;18(7):841–6. PMID: 18459025.PubMedCrossRef
5.
Zurück zum Zitat Ladosky W, Botelho MAM, Albuquerque JP. Chest mechanics in morbidily obese non-hypoventilated patients. Respir Med. 2001;95(4):281–6. PMID: 11316110.PubMedCrossRef Ladosky W, Botelho MAM, Albuquerque JP. Chest mechanics in morbidily obese non-hypoventilated patients. Respir Med. 2001;95(4):281–6. PMID: 11316110.PubMedCrossRef
6.
Zurück zum Zitat Koenig SM. Pulmonary complications of obesity. Am J Med Sci. 2001;321(4):249–79. PMID: 11307867.PubMedCrossRef Koenig SM. Pulmonary complications of obesity. Am J Med Sci. 2001;321(4):249–79. PMID: 11307867.PubMedCrossRef
7.
Zurück zum Zitat Lin WY, Yao CA, Wang HC, et al. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity (Silver Spring). 2006;14(9):1654–61. PMID: 17030977.CrossRef Lin WY, Yao CA, Wang HC, et al. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity (Silver Spring). 2006;14(9):1654–61. PMID: 17030977.CrossRef
8.
Zurück zum Zitat Mazess RB, Barden HS, Bisek JP, et al. Dual-energy X-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr. 1990;51(6):1106–12. PMID: 2349926.PubMed Mazess RB, Barden HS, Bisek JP, et al. Dual-energy X-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr. 1990;51(6):1106–12. PMID: 2349926.PubMed
9.
Zurück zum Zitat Mafort TT, Madeira M, Madeira M, et al. Intragastric balloon for the treatment of obesity: evaluation of pulmonary function over a 3-month period. Lung. 2012;190(6):671–6. Epub 2012 Sep 12. PMID: 22968677.PubMedCrossRef Mafort TT, Madeira M, Madeira M, et al. Intragastric balloon for the treatment of obesity: evaluation of pulmonary function over a 3-month period. Lung. 2012;190(6):671–6. Epub 2012 Sep 12. PMID: 22968677.PubMedCrossRef
10.
Zurück zum Zitat Santana H, Zoico E, Turcato E, et al. Relation between body composition, fat distribution, and lung function in elderly men. Am J Am J Clin Nutr. 2001;73(4):827–31. PMID: 11273860. Santana H, Zoico E, Turcato E, et al. Relation between body composition, fat distribution, and lung function in elderly men. Am J Am J Clin Nutr. 2001;73(4):827–31. PMID: 11273860.
11.
Zurück zum Zitat Wannamethee SG, Shaper AG, Whincup PH. Body fat distribution, body composition, and respiratory function in elderly men. Am J Clin Nutr. 2005;82(5):996–1003. PMID: 16280430.PubMed Wannamethee SG, Shaper AG, Whincup PH. Body fat distribution, body composition, and respiratory function in elderly men. Am J Clin Nutr. 2005;82(5):996–1003. PMID: 16280430.PubMed
12.
Zurück zum Zitat Thomas PS, Cowen ERT, Hulands G, et al. Respiratory function in the morbidly obese before and after weight loss. Thorax. 1989;44(5):382–6. PMID: 2503905.PubMedCrossRef Thomas PS, Cowen ERT, Hulands G, et al. Respiratory function in the morbidly obese before and after weight loss. Thorax. 1989;44(5):382–6. PMID: 2503905.PubMedCrossRef
13.
Zurück zum Zitat Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet. 2005;366(9491):1059–62. PMID: 16182882.PubMedCrossRef Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet. 2005;366(9491):1059–62. PMID: 16182882.PubMedCrossRef
15.
Zurück zum Zitat Pereira CAC, Rodrigues SC, Sato T. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol. 2007;33(4):397–406. PMID: 17982531.PubMedCrossRef Pereira CAC, Rodrigues SC, Sato T. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol. 2007;33(4):397–406. PMID: 17982531.PubMedCrossRef
16.
Zurück zum Zitat Neder JA, Andreoni S, Peres C, et al. Reference values for lung function tests. I. Static volumes. Braz J Med Biol Res. 1999;32(6):703–17. PMID: 10412549.PubMed Neder JA, Andreoni S, Peres C, et al. Reference values for lung function tests. I. Static volumes. Braz J Med Biol Res. 1999;32(6):703–17. PMID: 10412549.PubMed
17.
Zurück zum Zitat Neder JA, Andreoni S, Peres C, et al. Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor). Braz J Med Biol Res. 1999;32(6):729–37.PubMedCrossRef Neder JA, Andreoni S, Peres C, et al. Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor). Braz J Med Biol Res. 1999;32(6):729–37.PubMedCrossRef
18.
Zurück zum Zitat Neder JA, Andreoni S, Lerario MC, et al. Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res. 1999;32(6):719–27. PMID: 10412550.PubMed Neder JA, Andreoni S, Lerario MC, et al. Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res. 1999;32(6):719–27. PMID: 10412550.PubMed
19.
Zurück zum Zitat Blouin K, Boivin A, Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Bio. 2008;108(3–5):272–80. Epub 2007 Sep 7. PMID: 17945484.CrossRef Blouin K, Boivin A, Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Bio. 2008;108(3–5):272–80. Epub 2007 Sep 7. PMID: 17945484.CrossRef
20.
Zurück zum Zitat Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18(12):1611–7. Epub 2008 Jun 21. PMID: 18568377.PubMedCrossRef Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18(12):1611–7. Epub 2008 Jun 21. PMID: 18568377.PubMedCrossRef
21.
Zurück zum Zitat Carvalho MR, Jorge Z, Nobre E, et al. Intra-gastric ballon in the treatment of morbid obesity. Acta Med Port. 2011;24(4):489–98. Epub 2011 Dec 12. PMID: 22521004.PubMed Carvalho MR, Jorge Z, Nobre E, et al. Intra-gastric ballon in the treatment of morbid obesity. Acta Med Port. 2011;24(4):489–98. Epub 2011 Dec 12. PMID: 22521004.PubMed
22.
Zurück zum Zitat Genco A, López-Nava G, Wahlen C, et al. Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg. 2013;23(4):515–21. PMID: 23224509.PubMedCrossRef Genco A, López-Nava G, Wahlen C, et al. Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg. 2013;23(4):515–21. PMID: 23224509.PubMedCrossRef
23.
Zurück zum Zitat Lopez-Nava G, Rubio MA, Prados S, et al. BioEnterics® Intragastric Balloon (BIB®): single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg. 2011;21(1):5–9. Epub 2010 Mar 20. PMID: 20306153.PubMedCrossRef Lopez-Nava G, Rubio MA, Prados S, et al. BioEnterics® Intragastric Balloon (BIB®): single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg. 2011;21(1):5–9. Epub 2010 Mar 20. PMID: 20306153.PubMedCrossRef
24.
Zurück zum Zitat Mion F, Napoleon B, Roman S, et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obes Surg. 2005;15(4):510–6. PMID: 15946431.PubMedCrossRef Mion F, Napoleon B, Roman S, et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obes Surg. 2005;15(4):510–6. PMID: 15946431.PubMedCrossRef
25.
Zurück zum Zitat Plank LD. Dual-energy X-ray absorptiometry and body composition. Curr Opin Clin Nutr Metab Care. 2005;8(3):305–9. PMID: 15809534.PubMedCrossRef Plank LD. Dual-energy X-ray absorptiometry and body composition. Curr Opin Clin Nutr Metab Care. 2005;8(3):305–9. PMID: 15809534.PubMedCrossRef
26.
Zurück zum Zitat Dulloo AG, Jacquet J, Solinas G, et al. Body composition phenotypes in pathways to obesity and the metabolic syndrome. Int J Obes (Lond). 2010;34 Suppl 2:S4–17. PMID: 21151146.CrossRef Dulloo AG, Jacquet J, Solinas G, et al. Body composition phenotypes in pathways to obesity and the metabolic syndrome. Int J Obes (Lond). 2010;34 Suppl 2:S4–17. PMID: 21151146.CrossRef
27.
Zurück zum Zitat Dulloo AG, Montani JP. Body composition, inflammation and thermogenesis in pathways to obesity and the metabolic syndrome: an overview. Obes Rev. 2012;13 Suppl 2:1–5. PMID: 23107254.PubMedCrossRef Dulloo AG, Montani JP. Body composition, inflammation and thermogenesis in pathways to obesity and the metabolic syndrome: an overview. Obes Rev. 2012;13 Suppl 2:1–5. PMID: 23107254.PubMedCrossRef
28.
Zurück zum Zitat Forlano R, Ippolito AM, Iacobelis A, et al. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc. 2010;71:927–33. Epub 2009 Oct 27. PMID: 19863955.PubMedCrossRef Forlano R, Ippolito AM, Iacobelis A, et al. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc. 2010;71:927–33. Epub 2009 Oct 27. PMID: 19863955.PubMedCrossRef
29.
Zurück zum Zitat Mui WL, Ng EK, Tsung BY, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20(8):1128–32. PMID: 19015930.PubMedCrossRef Mui WL, Ng EK, Tsung BY, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20(8):1128–32. PMID: 19015930.PubMedCrossRef
30.
Zurück zum Zitat Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19(8):1084–8. Epub 2009 Jun 9. PMID: 19506981.PubMedCrossRef Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19(8):1084–8. Epub 2009 Jun 9. PMID: 19506981.PubMedCrossRef
31.
Zurück zum Zitat Despres JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler, Thromb, Vasc Biol. 2008;28(6):1039–49. PMID: 18356555.CrossRef Despres JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler, Thromb, Vasc Biol. 2008;28(6):1039–49. PMID: 18356555.CrossRef
33.
Zurück zum Zitat Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond). 2009;33(1):54–66. PMID: 19050672.CrossRef Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond). 2009;33(1):54–66. PMID: 19050672.CrossRef
34.
Zurück zum Zitat Lazarus R, Gore CJ, Booth M, et al. Effects of body composition and fat distribution on ventilatory function in adults. Am J Clin Nutr. 1998;68(1):35–41. PMID: 96655094.PubMed Lazarus R, Gore CJ, Booth M, et al. Effects of body composition and fat distribution on ventilatory function in adults. Am J Clin Nutr. 1998;68(1):35–41. PMID: 96655094.PubMed
35.
Zurück zum Zitat Ray CS, Sue DY, Bray G, et al. Effects of obesity on respiratory function. Am Rev Respir Dis. 1983;128(3):501–6. PMID: 6614644.PubMed Ray CS, Sue DY, Bray G, et al. Effects of obesity on respiratory function. Am Rev Respir Dis. 1983;128(3):501–6. PMID: 6614644.PubMed
36.
Zurück zum Zitat Jenkins SC, Moxham J. The effects of mild obesity on lung function. Respir Med. 1991;85(4):309–11. PMID: 1947368.PubMedCrossRef Jenkins SC, Moxham J. The effects of mild obesity on lung function. Respir Med. 1991;85(4):309–11. PMID: 1947368.PubMedCrossRef
37.
Zurück zum Zitat Chen Y, Rennie D, Cormier YF, et al. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr. 2007;85(1):35–9. PMID: 17209174.PubMed Chen Y, Rennie D, Cormier YF, et al. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr. 2007;85(1):35–9. PMID: 17209174.PubMed
39.
Zurück zum Zitat Medoff BD. Fat, fire and muscle—the role of adiponectin in pulmonary vascular inflammation and remodeling. Pulm Pharmacol Ther. 2013;26(4):420-426. PMID: 22750271 Medoff BD. Fat, fire and muscle—the role of adiponectin in pulmonary vascular inflammation and remodeling. Pulm Pharmacol Ther. 2013;26(4):420-426. PMID: 22750271
41.
Zurück zum Zitat Salome CM, King GG, Berend N. Physiology of obesity and effects on lung function. J Appl Physiol. 2010;108(1):206–11. PMID: 19875713.PubMedCrossRef Salome CM, King GG, Berend N. Physiology of obesity and effects on lung function. J Appl Physiol. 2010;108(1):206–11. PMID: 19875713.PubMedCrossRef
42.
Zurück zum Zitat Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America’s health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring). 2007;15(5):1061–7. PMID: 17455180.CrossRef Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America’s health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring). 2007;15(5):1061–7. PMID: 17455180.CrossRef
43.
Zurück zum Zitat Jones RL, Nzekwu MMU. The effects of body mass index on lung volumes. Chest. 2006;130(3):827–33. PMID: 16963682.PubMedCrossRef Jones RL, Nzekwu MMU. The effects of body mass index on lung volumes. Chest. 2006;130(3):827–33. PMID: 16963682.PubMedCrossRef
44.
45.
Zurück zum Zitat Ochs-Balcom HM, Grant BJ, Muti P, et al. Pulmonary function and abdominal obesity in the general population. Chest. 2006;129(4):853–62. PMID: 16608930.PubMedCrossRef Ochs-Balcom HM, Grant BJ, Muti P, et al. Pulmonary function and abdominal obesity in the general population. Chest. 2006;129(4):853–62. PMID: 16608930.PubMedCrossRef
Metadaten
Titel
Six-Month Intragastric Balloon Treatment for Obesity Improves Lung Function, Body Composition, and Metabolic Syndrome
verfasst von
Thiago Thomaz Mafort
Eduardo Madeira
Miguel Madeira
Erika Paniago Guedes
Rodrigo Oliveira Moreira
Laura Maria Carvalho de Mendonça
Maria Lucia Fleiuss Farias
Agnaldo José Lopes
Publikationsdatum
01.02.2014
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 2/2014
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-013-1061-5

Weitere Artikel der Ausgabe 2/2014

Obesity Surgery 2/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.